NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
DOI: | 10.36557/2674-8169.2024v6n2p1243-1251 |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1460 |
Resumo: | Neonatal sepsis (NS) is a clinical syndrome in which the patient shows systemic signs of infection, associated with the presence of bacteria, fungi or viruses in sterile fluids (blood or liquor) in the first month of life. NS is one of the main causes of neonatal death worldwide, and premature and low birth weight newborns (NB) are the most susceptible to developing it. A survey of articles published between 2011-2022 was carried out using PubMed, Scielo and Google Scholar. The search terms used were "Neonatal Sepsis" and "Neonatal Sepsis". Articles published in Portuguese or English were selected. As a result, it was found that neonatal sepsis is classified according to the time elapsed before the onset of signs and symptoms, being called early when it occurs in the first 72 hours of life and late when it occurs after these 72 hours. In this sense, the former is linked to the conditions of the delivery/mother and the NB at birth, while the latter is related to the use of medication, invasive procedures and hospitalization in Neonatal Intensive Care Units (NICUs). The clinical manifestations of this pathology are non-specific and are constantly confused with conditions of age/prematurity, consisting of difficulty breathing, tachycardia, lethargy, fever, jaundice with no other determining cause, vomiting, diarrhea and other alterations. Diagnosing NS is a challenge, since there is a lack of tools with optimum sensitivity for this, sometimes requiring several tests for confirmation. Even so, sometimes a diagnosis of clinical sepsis is made in order to immediately start antibiotic therapy, which is the basis of treatment for neonatal sepsis. |
id |
GOE-1_0f554bb80742f0ba669d7817825aab4c |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1460 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
spelling |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENTSEPSIS NEONATAL: RETOS EN EL DIAGNÓSTICO Y TRATAMIENTOSEPSE NEONATAL: DESAFIOS NO DIAGNÓSTICO E TRATAMENTOSepse NeonatalPrematuridadeAntibioticoterapiaNeonatal SepsisPrematurityAntibiotic TherapySepsis neonatalPrematuridadTerapia antibióticaNeonatal sepsis (NS) is a clinical syndrome in which the patient shows systemic signs of infection, associated with the presence of bacteria, fungi or viruses in sterile fluids (blood or liquor) in the first month of life. NS is one of the main causes of neonatal death worldwide, and premature and low birth weight newborns (NB) are the most susceptible to developing it. A survey of articles published between 2011-2022 was carried out using PubMed, Scielo and Google Scholar. The search terms used were "Neonatal Sepsis" and "Neonatal Sepsis". Articles published in Portuguese or English were selected. As a result, it was found that neonatal sepsis is classified according to the time elapsed before the onset of signs and symptoms, being called early when it occurs in the first 72 hours of life and late when it occurs after these 72 hours. In this sense, the former is linked to the conditions of the delivery/mother and the NB at birth, while the latter is related to the use of medication, invasive procedures and hospitalization in Neonatal Intensive Care Units (NICUs). The clinical manifestations of this pathology are non-specific and are constantly confused with conditions of age/prematurity, consisting of difficulty breathing, tachycardia, lethargy, fever, jaundice with no other determining cause, vomiting, diarrhea and other alterations. Diagnosing NS is a challenge, since there is a lack of tools with optimum sensitivity for this, sometimes requiring several tests for confirmation. Even so, sometimes a diagnosis of clinical sepsis is made in order to immediately start antibiotic therapy, which is the basis of treatment for neonatal sepsis.La sepsis neonatal (SN) es un síndrome clínico en el que el paciente muestra signos sistémicos de infección, asociados a la presencia de bacterias, hongos o virus en fluidos estériles (sangre o licor) en el primer mes de vida. El síndrome neonatal es una de las principales causas de muerte neonatal en todo el mundo, y los recién nacidos prematuros y de bajo peso al nacer (RN) son los más susceptibles de desarrollarlo. Se realizó un estudio de los artículos publicados entre 2011-2022 utilizando PubMed, Scielo y Google Scholar. Los términos de búsqueda utilizados fueron "Neonatal Sepsis" y "Neonatal Sepsis". Se seleccionaron artículos publicados en portugués o inglés. Como resultado, se encontró que la sepsis neonatal se clasifica de acuerdo con el tiempo transcurrido antes del inicio de los signos y síntomas, denominándose precoz cuando ocurre en las primeras 72 horas de vida y tardía cuando ocurre después de las 72 horas. En este sentido, la primera está vinculada a las condiciones del parto/madre y del RN al nacer, mientras que la segunda se relaciona con el uso de medicación, procedimientos invasivos y hospitalización en Unidades de Cuidados Intensivos Neonatales (UCIN). Las manifestaciones clínicas de esta patología son inespecíficas y se confunden constantemente con condiciones propias de la edad/prematuridad, consistiendo en dificultad respiratoria, taquicardia, letargia, fiebre, ictericia sin otra causa determinante, vómitos, diarrea y otras alteraciones. El diagnóstico de la SN es todo un reto, ya que se carece de herramientas con una sensibilidad óptima para ello, requiriéndose en ocasiones varias pruebas para su confirmación. Aun así, a veces se realiza un diagnóstico de sepsis clínica para iniciar inmediatamente la antibioterapia, que constituye la base del tratamiento de la sepsis neonatal.A sepse neonatal (SN) é uma sindrome clínica na qual o paciente apresenta sinais sistêmicos de infecção, associados à presença de bactérias, fungos ou vírus em líquidos estéreis (sangue ou licor) no primeiro mês de vida. A SN é uma das principais causas de morte neonatal no mundo, sendo os prematuros e recém-nascidos (RN) com baixo peso ao nascer, os mais suscetíveis a desenvolvê-la. Realizou-se um levantamento de artigos publicados entre 2011-2022, utilizando PubMed, Scielo e Google Scholar. Utilizou-se como termos de busca “Neonatal Sepsis” e “Sepse Neonatal”. Foram selecionados artigos publicados em português ou inglês. Com isso, foi obtido que a sepse neonatal é classificada quanto ao tempo de vida decorrido para o início dos sinais e sintomas, sendo denominada precoce quando ocorre nas primeiras 72 horas de vida e, tardia quando após essas 72 horas. Nesse sentido, a primeira está ligada às condições do parto/mãe e do RN ao nascimento, enquanto a segunda se relaciona ao uso de medicamentos, procedimentos invasivos e internação em Unidades de Terapia Intensiva Neonatal (UTIN). As manifestações clínicas dessa patologia são inespecíficas e constantemente são confundidas com condições da idade/prematuridade, sendo compostas por dificuldade respiratória, taquicardia, letargia, febre, icterícia sem outra causa determinante, vômitos, diarreia e outras alterações. O diagnóstico da SN é um desafio, uma vez que falta ferramentas com ótima sensibilidade para tal, necessitando, por vezes, de diversos exames para a confirmação. Ainda assim, em alguns momentos, é feito o diagnóstico de sepse clínica para início imediato da antibioticoterapia, que constitui a base do tratamento da sepse neonatal.Specialized Dentistry Group2024-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/146010.36557/2674-8169.2024v6n2p1243-1251Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 2 (2024): BJIHS QUALIS B3; 1243-1251Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 2 (2024): BJIHS QUALIS B3; 1243-1251Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 2 (2024): BJIHS QUALIS B3; 1243-12512674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1460/1652Copyright (c) 2024 Humberto Novais da Conceição, Marina Pezzetti Sanchez Diogo, Patrícia Jacques da Silva, Luiz Eduardo Rangel de Araújo, Isabella Alves Barbosa Dorneles, Juarez Soares Dorneles Neto, Luciano Hirt, Fabiana de Castro Machado , Davi Rebello Misukami , Gabriella Mariane Freire Ramos, Cristiano Rafael Huff, Bruno Gonzaga Feitozahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessNovais da Conceição, HumbertoPezzetti Sanchez Diogo, MarinaJacques da Silva, Patrícia Eduardo Rangel de Araújo, LuizAlves Barbosa Dorneles, IsabellaSoares Dorneles Neto, JuarezHirt, Lucianode Castro Machado , FabianaRebello Misukami , DaviMariane Freire Ramos, GabriellaRafael Huff, CristianoGonzaga Feitoza, Bruno2024-02-14T17:13:44Zoai:ojs.bjihs.emnuvens.com.br:article/1460Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-02-14T17:13:44Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT SEPSIS NEONATAL: RETOS EN EL DIAGNÓSTICO Y TRATAMIENTO SEPSE NEONATAL: DESAFIOS NO DIAGNÓSTICO E TRATAMENTO |
title |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
spellingShingle |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT Novais da Conceição, Humberto Sepse Neonatal Prematuridade Antibioticoterapia Neonatal Sepsis Prematurity Antibiotic Therapy Sepsis neonatal Prematuridad Terapia antibiótica Novais da Conceição, Humberto Sepse Neonatal Prematuridade Antibioticoterapia Neonatal Sepsis Prematurity Antibiotic Therapy Sepsis neonatal Prematuridad Terapia antibiótica |
title_short |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
title_full |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
title_fullStr |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
title_full_unstemmed |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
title_sort |
NEONATAL SEPSIS: CHALLENGES IN DIAGNOSIS AND TREATMENT |
author |
Novais da Conceição, Humberto |
author_facet |
Novais da Conceição, Humberto Novais da Conceição, Humberto Pezzetti Sanchez Diogo, Marina Jacques da Silva, Patrícia Eduardo Rangel de Araújo, Luiz Alves Barbosa Dorneles, Isabella Soares Dorneles Neto, Juarez Hirt, Luciano de Castro Machado , Fabiana Rebello Misukami , Davi Mariane Freire Ramos, Gabriella Rafael Huff, Cristiano Gonzaga Feitoza, Bruno Pezzetti Sanchez Diogo, Marina Jacques da Silva, Patrícia Eduardo Rangel de Araújo, Luiz Alves Barbosa Dorneles, Isabella Soares Dorneles Neto, Juarez Hirt, Luciano de Castro Machado , Fabiana Rebello Misukami , Davi Mariane Freire Ramos, Gabriella Rafael Huff, Cristiano Gonzaga Feitoza, Bruno |
author_role |
author |
author2 |
Pezzetti Sanchez Diogo, Marina Jacques da Silva, Patrícia Eduardo Rangel de Araújo, Luiz Alves Barbosa Dorneles, Isabella Soares Dorneles Neto, Juarez Hirt, Luciano de Castro Machado , Fabiana Rebello Misukami , Davi Mariane Freire Ramos, Gabriella Rafael Huff, Cristiano Gonzaga Feitoza, Bruno |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Novais da Conceição, Humberto Pezzetti Sanchez Diogo, Marina Jacques da Silva, Patrícia Eduardo Rangel de Araújo, Luiz Alves Barbosa Dorneles, Isabella Soares Dorneles Neto, Juarez Hirt, Luciano de Castro Machado , Fabiana Rebello Misukami , Davi Mariane Freire Ramos, Gabriella Rafael Huff, Cristiano Gonzaga Feitoza, Bruno |
dc.subject.por.fl_str_mv |
Sepse Neonatal Prematuridade Antibioticoterapia Neonatal Sepsis Prematurity Antibiotic Therapy Sepsis neonatal Prematuridad Terapia antibiótica |
topic |
Sepse Neonatal Prematuridade Antibioticoterapia Neonatal Sepsis Prematurity Antibiotic Therapy Sepsis neonatal Prematuridad Terapia antibiótica |
description |
Neonatal sepsis (NS) is a clinical syndrome in which the patient shows systemic signs of infection, associated with the presence of bacteria, fungi or viruses in sterile fluids (blood or liquor) in the first month of life. NS is one of the main causes of neonatal death worldwide, and premature and low birth weight newborns (NB) are the most susceptible to developing it. A survey of articles published between 2011-2022 was carried out using PubMed, Scielo and Google Scholar. The search terms used were "Neonatal Sepsis" and "Neonatal Sepsis". Articles published in Portuguese or English were selected. As a result, it was found that neonatal sepsis is classified according to the time elapsed before the onset of signs and symptoms, being called early when it occurs in the first 72 hours of life and late when it occurs after these 72 hours. In this sense, the former is linked to the conditions of the delivery/mother and the NB at birth, while the latter is related to the use of medication, invasive procedures and hospitalization in Neonatal Intensive Care Units (NICUs). The clinical manifestations of this pathology are non-specific and are constantly confused with conditions of age/prematurity, consisting of difficulty breathing, tachycardia, lethargy, fever, jaundice with no other determining cause, vomiting, diarrhea and other alterations. Diagnosing NS is a challenge, since there is a lack of tools with optimum sensitivity for this, sometimes requiring several tests for confirmation. Even so, sometimes a diagnosis of clinical sepsis is made in order to immediately start antibiotic therapy, which is the basis of treatment for neonatal sepsis. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1460 10.36557/2674-8169.2024v6n2p1243-1251 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1460 |
identifier_str_mv |
10.36557/2674-8169.2024v6n2p1243-1251 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1460/1652 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 2 (2024): BJIHS QUALIS B3; 1243-1251 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 2 (2024): BJIHS QUALIS B3; 1243-1251 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 2 (2024): BJIHS QUALIS B3; 1243-1251 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1822182034099929088 |
dc.identifier.doi.none.fl_str_mv |
10.36557/2674-8169.2024v6n2p1243-1251 |